Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 19 Jun 2023 |
2 | Journal Copy | 29 Jan 2024 |
3 | TM-O(NOTICE OF OPPOSITION) | 04 Apr 2024 |
4 | Evidence Affidavit Under Rule 46 (TOP) | 03 Oct 2024 |
5 | Annexure -1 under rule 46 | 03 Oct 2024 |
1 | Opposition Notice | 17958263 | 6690636 | 15 Apr 2024 |
2 | Opposition Counter Statement | 18321555 | 6766304 | 14 Jun 2024 |
3 | Opposition Counter Statement | 18321626 | 6766313 | 14 Jun 2024 |
The application for Afreba was made on 19 June 2023.
The trademark applicant for Afreba is STRIDES PHARMA SCIENCE.
Afreba is applied in class(es) 5.
Application for Afreba is on Opposed stage.
Application Id allotted to Afreba is 5985869.
Trademark agent or attorney for the application is Altacit Global.
Afreba filed with the Intellectual property office as a WORD.